VERONA PHARMA PLC. — Operating Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7a4ada71-b2b3-4b4e-81c9-73fa54845cd6/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-154.6M | 2024-01-01 – 2024-12-31 | evidence 0001657312-25-000010 |
| FY 2023 | $-67.6M | 2023-01-01 – 2023-12-31 | evidence 0001657312-24-000007 |
| FY 2022 | $-75.8M | 2022-01-01 – 2022-12-31 | evidence 0001657312-23-000006 |
| FY 2021 | $-73.3M | 2021-01-01 – 2021-12-31 | evidence 0001657312-22-000010 |
| FY 2020 | $-74.3M | 2020-01-01 – 2020-12-31 | evidence 0001657312-21-000004 |
| FY 2019 | $-52.4M | 2019-01-01 – 2019-12-31 | evidence 0001657312-21-000004 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).